Search

Your search keyword '"low density lipoprotein modifications"' showing total 2 results
Start Over Descriptor "low density lipoprotein modifications"
2 results on '"low density lipoprotein modifications"'

1. Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies

Author

Gabriel Virella, Suzanne R. Thorpe, Nathan L. Alderson, M. Brooks Derrick, Charlyne Chassereau, J. Matthew Rhett, and Maria F. Lopes-Virella

Subjects
low density lipoprotein modifications, low density lipoprotein autoantibodies, modified low density lipoprotein antibodies, immunology of atherosclerosis, autoimmunity, atherosclerosis, Biochemistry, QD415-436
Abstract

Humans and laboratory animals recognize human modified LDL as immunogenic. Immune complexes (ICs) isolated from human sera contain malondialdehyde-modified LDL (MDA-LDL) and N ε(carboxymethyl)lysine-modified LDL (CML-LDL) as well as antibodies reacting with MDA-LDL, copper-oxidized LDL (OxLDL), CML-LDL, and advanced glycosylation end product (AGE)-modified LDL. OxLDL and AGE-LDL antibodies isolated from human sera recognize the same LDL modifications and do not react with modified non-LDL proteins. Rabbit antibodies have different reactivity patterns: MDA-LDL antibodies react strongly with MDA-LDL and MDA-BSA but weakly with OxLDL; OxLDL antibodies react strongly with OxLDL and weakly with MDA-LDL; CML-LDL antibodies react with CML-LDL > CML-BSA > AGE-LDL > OxLDL; AGE-LDL antibodies react strongly with AGE-LDL, react weakly with OxLDL, and do not react with CML-LDL. Thus, human and rabbit antibodies seem to recognize different epitopes. Capture assays carried out with all rabbit antibodies showed binding of apolipoprotein B-rich lipoproteins isolated from ICs, suggesting that laboratory-generated epitopes are expressed by in vivo-modified LDL, although they are not necessarily recognized by the human immune system.Thus, the definition of immunogenic forms of modified LDL eliciting human autoimmune responses requires the isolation and characterization of autoantibodies and modified LDL from human samples, whereas rabbit antibodies can be used to detect in vivo-modified human LDL.

Published
2004
Full Text
View/download PDF

2. Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies

Author

M. Brooks Derrick, N. L. Alderson, J. Matthew Rhett, Charlyne Chassereau, Suzanne R. Thorpe, Gabriel Virella, and Maria F. Lopes-Virella

Subjects
Glycation End Products, Advanced, low density lipoprotein modifications, Glycosylation, Apolipoprotein B, Antibodies, Heterophile, QD415-436, Autoimmune responses, Antigen-Antibody Complex, Cross Reactions, medicine.disease_cause, Biochemistry, Epitope, Autoimmunity, chemistry.chemical_compound, Epitopes, Endocrinology, Immune system, modified low density lipoprotein antibodies, Antibody Specificity, medicine, Animals, Humans, Apolipoproteins B, Autoantibodies, biology, autoimmunity, Autoantibody, Cell Biology, Lipoproteins, LDL, chemistry, Immunology, immunology of atherosclerosis, biology.protein, lipids (amino acids, peptides, and proteins), Rabbits, atherosclerosis, Antibody, low density lipoprotein autoantibodies
Abstract

Humans and laboratory animals recognize human modified LDL as immunogenic. Immune complexes (ICs) isolated from human sera contain malondialdehyde-modified LDL (MDA-LDL) and N (epsilon)(carboxymethyl)lysine-modified LDL (CML-LDL) as well as antibodies reacting with MDA-LDL, copper-oxidized LDL (OxLDL), CML-LDL, and advanced glycosylation end product (AGE)-modified LDL. OxLDL and AGE-LDL antibodies isolated from human sera recognize the same LDL modifications and do not react with modified non-LDL proteins. Rabbit antibodies have different reactivity patterns: MDA-LDL antibodies react strongly with MDA-LDL and MDA-BSA but weakly with OxLDL; OxLDL antibodies react strongly with OxLDL and weakly with MDA-LDL; CML-LDL antibodies react with CML-LDL > CML-BSA > AGE-LDL > OxLDL; AGE-LDL antibodies react strongly with AGE-LDL, react weakly with OxLDL, and do not react with CML-LDL. Thus, human and rabbit antibodies seem to recognize different epitopes. Capture assays carried out with all rabbit antibodies showed binding of apolipoprotein B-rich lipoproteins isolated from ICs, suggesting that laboratory-generated epitopes are expressed by in vivo-modified LDL, although they are not necessarily recognized by the human immune system. Thus, the definition of immunogenic forms of modified LDL eliciting human autoimmune responses requires the isolation and characterization of autoantibodies and modified LDL from human samples, whereas rabbit antibodies can be used to detect in vivo-modified human LDL.

Published
2004

Catalog

Books, media, physical & digital resources
See catalog results